LIFECORE BIOMEDICAL, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIFECORE BIOMEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2025-05-25 was -$8.00K.
- LIFECORE BIOMEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2025-02-23 was $16.00K.
- LIFECORE BIOMEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2024-11-24 was $23.84M.
- LIFECORE BIOMEDICAL, INC. stock issued during period, value, new issues for the quarter ending 2024-02-25 was $0.00.
- LIFECORE BIOMEDICAL, INC. stock issued during period, value, new issues for fiscal 2025 was $23.85M.
- LIFECORE BIOMEDICAL, INC. stock issued during period, value, new issues for fiscal 2023 was $4.82M, a 482100.00% increase from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. stock issued during period, value, new issues for fiscal 2022 was $1.00K.
- LIFECORE BIOMEDICAL, INC. stock issued during period, value, new issues for fiscal 2020 was $30.00K, a 90.83% decline from fiscal 2019.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-05-25 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $23.85M 10-KT · filed 2026-03-16 |
| 2025-02-23 | $16.00K 10-Q · filed 2026-05-06 | |
| 2024-11-24 | $23.84M 10-Q · filed 2025-01-02 | |
| 2024-02-25 | $0.00 10-Q · filed 2025-04-03 | |
| 2023-05-28 | $4.82M 10-K · filed 2024-08-26 | |
| 2022-11-27 | $4.82M 10-Q · filed 2024-08-09 | |
| 2022-08-28 | $0.00 10-Q/A · filed 2023-03-16 | |
| 2022-05-29 | $1.00K 10-K/A · filed 2023-03-16 | |
| 2022-02-27 | $0.00 10-Q · filed 2022-04-07 | |
| 2021-11-28 | $0.00 10-Q · filed 2022-04-07 | |
| 2021-08-29 | $0.00 10-Q/A · filed 2023-03-16 | |
| 2021-02-28 | $0.00 10-Q · filed 2022-04-07 | |
| 2020-11-29 | $0.00 10-Q · filed 2022-04-07 | |
| 2020-08-30 | $0.00 10-Q · filed 2022-04-07 | |
| 2020-05-31 | $30.00K 10-K/A · filed 2023-03-16 | |
| 2020-02-23 | $0.00 10-Q · filed 2021-04-08 | |
| 2019-11-24 | $30.00K 10-Q · filed 2021-04-08 | |
| 2019-08-25 | $0.00 10-Q · filed 2021-04-08 | |
| 2019-05-26 | $327.00K 10-K · filed 2021-07-29 | |
| 2019-02-24 | $230.00K 10-Q · filed 2020-04-03 | |
| 2018-11-25 | $0.00 10-Q · filed 2020-04-03 | |
| 2018-08-26 | $0.00 10-Q · filed 2020-04-03 | |
| 2017-02-26 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |